FDA grants fast track designation to azer-cel, an allogeneic CAR T-cell therapy, for relapsed or refractory diffuse large ...

Although chimeric antigen receptor T-cell therapy has raised hopes for long-term remission in autoimmune disease, it has ...

One of the lab’s major projects is to characterize the roles that cytokine-producing “effector” B cells play in modulating inflammation and T cell-mediated immune responses to pathogens, autoantigens ...

Among 11 patients with large B-cell lymphomas other than de novo ... severe cytokine release syndrome, or immune effector cell-associated neurotoxicity syndrome." They added that while the ...

Certain proteins in cerebrospinal fluid could act as key indicators for a harmful side effect of cancer immunotherapy, ...

"Forty-one study patients (38 with diffuse large B-cell lymphoma (DLBCL ... laryngeal edema contained a higher proportion of effector T-cells compared to those without edema.